1. Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing
    Zoi Piperigkou et al, 2017, Advanced Drug Delivery Reviews CrossRef
  2. Assessing miRNAs profile expression as a risk stratification biomarker in oral potentially malignant disorders: A systematic review
    Haytham El-Sakka et al, 2018, Oral Oncology CrossRef
  3. The role of small noncoding RNAS in the pathogenesis of coronary arteries atherosclerosis
    E. A. Polyakova et al, 2018, Transl. med. (Print) CrossRef
  4. MiR-203 regulates keloid fibroblast proliferation, invasion, and extracellular matrix expression by targeting EGR1 and FGF2
    Kai Shi et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  5. Pathogenesis investigation of miR-199-5p in oral submucous fibrosis based on bioinformatics analysis
    Yongxiang Yuan et al, 2018, Oral Dis CrossRef
  6. Oral submucous fibrosis: A global challenge. Rising incidence, risk factors, management, and research priorities
    Jay Gopal Ray et al, 2019, Periodontol 2000 CrossRef
  7. The pharmacology, toxicology and potential applications of arecoline: a review
    Yu-Jie Liu et al, 2016, Pharmaceutical Biology CrossRef
  8. Chemistry, metabolism and pharmacology of carcinogenic alkaloids present in areca nut and factors affecting their concentration
    Alpana K. Gupta et al, 2019, Regulatory Toxicology and Pharmacology CrossRef
  9. MicroRNA-203 restrains epithelial–mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3
    Anmin You et al, 2020, Cell Cycle CrossRef
  10. TM4SF1 involves in miR-1-3p/miR-214-5p-mediated inhibition of the migration and proliferation in keloid by regulating AKT/ERK signaling
    Mingyuan Xu et al, 2020, Life Sciences CrossRef
  11. Association of myocardial and serum miRNA expression patterns with the presence and extent of coronary artery disease: A cross-sectional study
    E.A. Polyakova et al, 2020, International Journal of Cardiology CrossRef
  12. Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer
    Fangmei Fu et al, 2020, Front. Mol. Biosci. CrossRef
  13. Expression and methylation of Dickkopf‐1 in the pathogenesis and malignant transformation of oral submucous fibrosis
    Xiufang He et al, 2020, J Oral Pathol Med CrossRef
  14. Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation
    Mohit Sharma et al, 2020, Int J Oral Sci CrossRef
  15. Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments
    Yen-Wen Shen et al, 2020, IJMS CrossRef
  16. Downregulation of the DNA Repair Gene DDB2 by Arecoline Is through p53’s DNA-Binding Domain and Is Correlated with Poor Outcome of Head and Neck Cancer Patients with Betel Quid Consumption
    Yu-Chu Wang et al, 2020, Cancers CrossRef
  17. Polydatin inhibits ZEB1-invoked epithelial-mesenchymal transition in fructose-induced liver fibrosis.
    Xiaojuan Zhao et al, 2020, J Cell Mol Med CrossRef
  18. A Review on Role of Arecoline and Its Metabolites in the Molecular Pathogenesis of Oral Lesions with an Insight into Current Status of Its Metabolomics
    Aparajita Das et al, 2020, Prague Med. Rep. CrossRef
  19. Areca catechu : A phytopharmacological legwork
    Abdullah Ansari et al, 2021, Food Frontiers CrossRef
  20. Arecoline induces epithelial‐mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression
    Hui Ren et al, 2021, Cancer Sci CrossRef
  21. The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis
    Pei-Ling Hsieh et al, 2021, Journal of Dental Sciences CrossRef
  22. Tanshinone Suppresses Arecoline-Induced EpithelialMesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway
    Lian Zheng et al, 2018, oncol res CrossRef
  23. Long Non-Coding RNAs in Oral Submucous Fibrosis: Their Functional Mechanisms and Recent Research Progress
    Yaodong He et al, 2021, JIR CrossRef
  24. Global identification of circular RNAs in imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145/miR-203/ABL1 and circ 0051886/miR-637/ABL1
    Yao-hua Lu et al, 2021, Mol Med CrossRef
  25. Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis
    Jyothsna Manikkath et al, 2022, Nanomedicine CrossRef
  26. Molecular Mechanisms of Malignant Transformation of Oral Submucous Fibrosis by Different Betel Quid Constituents—Does Fibroblast Senescence Play a Role?
    Pangzhen Zhang et al, 2022, IJMS CrossRef
  27. Changes in microRNA expression in the urine and endotelium-dependent regulation of vassel tone in Wistar rats received a high-salt diet
    V. I. Zaraiski et al, 2022, Nefrologiâ (St.-Peterbg.) CrossRef
  28. Comprehensive analysis of microRNAs and their target genes in oral submucous fibrosis
    Padacherri Vethil Jishnu et al, 2022, Oral Diseases CrossRef
  29. Is Epithelial-Mesenchymal Transition a New Roadway in the Pathogenesis of Oral Submucous Fibrosis: A Comprehensive Review
    Abikshyeet Panda et al, 2022 CrossRef
  30. The role of altered microRNA expression in premalignant and malignant head and neck lesions with epithelial origin.
    Alieh Farshbaf et al, 2022, Health Sci Rep CrossRef
  31. A Critical Interpretive Synthesis of the Role of Arecoline in Oral Carcinogenesis: Is the Local Cholinergic Axis a Missing Link in Disease Pathophysiology?
    Hakan Gocol et al, 2023, Pharmaceuticals CrossRef
  32. Pivotal role of MiRNA's in malignant transformation of Oral Submucous Fibrosis
    J.H. Shazia Fathima et al, 2024, Oral Oncology Reports CrossRef
  33. The role of MicroRNAs in the diagnosis and treatment of oral premalignant disorders
    J. H. Shazia Fathima et al, 2024, Odontology CrossRef
  34. circMTO1/miR‐30c‐5p/SOCS3 axis alleviates oral submucous fibrosis through inhibiting fibroblast–myofibroblast transition
    Xin Bin et al, 2024, J Oral Pathology Medicine CrossRef
  35. Role of Stem Cells in the Pathogenesis and Malignant Transformation of Oral Submucous Fibrosis
    Suvarna Kizhakkoottu et al, 2024, Stem Cell Rev and Rep CrossRef
  36. MicroRNA-503 Suppresses Oral Mucosal Fibroblast Differentiation by Regulating RAS/RAF/MEK/ERK Signaling Pathway
    Dada Wen et al, 2024, Biomolecules CrossRef